New drug trial targets Hard-to-Treat cancers

NCT ID NCT06476808

Recruiting now Disease control Sponsor: Bristol-Myers Squibb Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 21, 2026 · Updated 2 times

Summary

This early-phase study tests a new drug called BMS-986463 in people with advanced ovarian, uterine, or lung cancer that has spread or cannot be removed by surgery. The main goals are to check safety and find the best dose. About 240 participants will receive the drug, and researchers will monitor side effects and how well the tumors respond.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

endometrial serous adenocarcinoma non-small cell lung carcinoma ovarian serous adenocarcinoma

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

HIGH-GRADE SEROUS OVARIAN CARCINOMA (HGSOC) NON-SMALL CELL LUNG CANCER (NSCLC) UTERINE SEROUS CARCINOMA (USC)

Contacts and locations

Locations

BC Cancer Vancouver
RECRUITING

Vancouver, British Columbia, V5Z 4E6, Canada
Centre Hospitalier de l'Université de Montréal
RECRUITING

Montreal, Quebec, H2X 3E4, Canada
Jewish General Hospital
RECRUITING

Montreal, Quebec, H3T 1E2, Canada
John Theurer Cancer Center at Hackensack University Medical Center
RECRUITING

Hackensack, New Jersey, 07601, United States
Local Institution - 0031
NOT_YET_RECRUITING

Villejuif, Val-de-Marne, 94800, France
Local Institution - 0032
NOT_YET_RECRUITING

Milan, 20159, Italy
Local Institution - 0033
NOT_YET_RECRUITING

Milan, 20141, Italy
Local Institution - 0035
NOT_YET_RECRUITING

Lyon, 69373, France
Local Institution - 0036
NOT_YET_RECRUITING

Bordeaux, Aquitaine, 33076, France
Local Institution - 0041
NOT_YET_RECRUITING

Avda.Pio XII 36,, 31008, Spain
Local Institution - 0042
NOT_YET_RECRUITING

Barcelona, Barcelona [Barcelona], 08035, Spain
Local Institution - 0045
NOT_YET_RECRUITING

Columbus, Ohio, 43210, United States
Local Institution - 0046
WITHDRAWN

Dallas, Texas, 75390, United States
Local Institution - 0049
NOT_YET_RECRUITING

Houston, Texas, 77054, United States
Princess Margaret Cancer Centre
RECRUITING

Toronto, Ontario, M5G 2M9, Canada
USC/Norris Comprehensive Cancer Center
RECRUITING

Los Angeles, California, 90033, United States
Valkyrie Clinical Trials
RECRUITING

Los Angeles, California, 90067, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.